RETRACTED: Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity
Ivermectin is an anti-parasitic agent that has gained attention as a potential COVID-19 therapeutic. It is a compound of the type Avermectin, which is a fermented by-product of Streptomyces avermitilis . Bifidobacterium is a member of the same phylum as Streptomyces spp., suggesting it may have a sy...
Gespeichert in:
Veröffentlicht in: | Frontiers in microbiology 2022-07, Vol.13 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Ivermectin is an anti-parasitic agent that has gained attention as a potential COVID-19 therapeutic. It is a compound of the type Avermectin, which is a fermented by-product of
Streptomyces avermitilis
.
Bifidobacterium
is a member of the same phylum as
Streptomyces
spp., suggesting it may have a symbiotic relation with
Streptomyces
. Decreased
Bifidobacterium
levels are observed in COVID-19 susceptibility states, including old age, autoimmune disorder, and obesity. We hypothesize that Ivermectin, as a by-product of
Streptomyces
fermentation, is capable of feeding
Bifidobacterium
, thereby possibly preventing against COVID-19 susceptibilities. Moreover,
Bifidobacterium
may be capable of boosting natural immunity, offering more direct COVID-19 protection. These data concord with our study, as well as others, that show Ivermectin protects against COVID-19. |
---|---|
ISSN: | 1664-302X 1664-302X |
DOI: | 10.3389/fmicb.2022.952321 |